LifeSensors ubiquitin ligase and proteasome inhibitors
LifeSensors has added several small molecule ubiquitin ligase and proteasome inhibitors to its range.
Carfilzomib is the active ingredient in the new clinical proteasome inhibitor Kyprolis.
Epoxomicin/BU-4061T is one of the most potent and selective proteasome inhibitors.
Oprozomib/ONX0912 is a clinical-stage proteasome inhibitor that selectively inhibits the chymotrypsin-like activity of the 20S proteasome.
MLN2238 is a potent inhibitor of the chymotrypsin-like activity of the 20S proteasome.
RITA/NSC652287 blocks p53-hdm2 interaction and p53 ubiquitination.
SKPin C1 inhibits the cullin-RING ubiquitin E3 ligase SCF-Skp2.
Phone: 02 4575 0309
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...
Learn More
I am interested in LifeSensors ubiquitin ligase and proteasome inhibitors.
Complete the form and a supplier representative will be in touch.
